The Conversation: COVID-19 drug and vaccine patents are putting profit before people
Ronald Labonte, professor and distinguished research chair for Globalization and Health Equity at the University of Ottawa, and Mira Johri, professeure titulaire at École de santé publique at the Université de Montréal (11/5).

The Conversation: As the malaria season begins in southern Africa, COVID-19 complicates the picture
Jaishree Raman, head of the Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research at the National Institute for Communicable Diseases, and Shüné Oliver, medical scientist at the National Institute for Communicable Diseases (11/5).

Financial Times: Danish mink cull highlights the unknowns of Covid-19
Editorial Board (11/6).

Foreign Affairs: China Is Winning the Vaccine Race
Eyck Freymann, author, and Justin Stebbing, professor of cancer medicine and oncology at Imperial College London (11/5).

The Hill: Vaccine race creates blind spots
Dale Chappell, chief scientific officer at Humanigen (11/5).

IPS: U.N. Takes Preventive Measures Following 5,660 Lab-Confirmed COVID-19 Cases System-Wide
Antonio Guterres, secretary general of the United Nations (11/6).

The Lancet: COVID-19 in Latin America: a humanitarian crisis
Editorial Board (11/7).

The Lancet Child & Adolescent Health: Growing up in the shadow of COVID-19
Editorial Board (11/5).

STAT: The hidden public health hazard of rapid Covid-19 tests
Joia Crear-Perry, OB-GYN and founder and president of the National Birth Equity Collaborative (11/5).

STAT: Far more transparency is needed for Covid-19 vaccine trials
Jennifer E. Miller, assistant professor at Yale School of Medicine and founder of Bioethics International, and colleagues (11/5).